Cynomolgus Guanylyl cyclase C/GUCY2C protein (Recombinant) (C-His) (STJP020279)
SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Cynomolgus Guanylyl cyclase C/GUCY2C Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser24-Gln430) of cynomolgus Guanylyl cyclase C/GUCY2C (Accession #XP_005570270.1) fused with His ta
General Information
| Short Description | Recombinant-Cynomolgus Guanylyl cyclase C/GUCY2C-C-His protein was developed in hek293 cells using the region Ser24-Gln430. For use in research applications. |
| Host | HEK293 cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant Cynomolgus Guanylyl cyclase C/GUCY2C Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Ser24-Gln430) of cynomolgus Guanylyl cyclase C/GUCY2C (Accession #XP_005570270.1) fused with His ta |
| Immunogen Region | Ser24-Gln430 |
Additional Info
| Background | Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatichanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy. |
Information sourced from Uniprot.org